首页 > 最新文献

Frontiers in Pediatrics最新文献

英文 中文
Beyond anti-VEGF: expanding the therapeutic horizon and biomarker landscape in retinopathy of prematurity. 超越抗vegf:扩大早产儿视网膜病变的治疗范围和生物标志物景观。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-30 eCollection Date: 2025-01-01 DOI: 10.3389/fped.2025.1713783
Yuxin Zhang, Qian Chen, Jianli Lv

Background: Retinopathy of prematurity (ROP) remains a leading cause of childhood blindness worldwide. While anti-VEGF therapy has revolutionized ROP treatment, concerns regarding systemic absorption, potential neurodevelopmental impacts, and late reactivation have spurred the quest for alternative therapeutic approaches. This mini-review examines emerging therapeutic targets and novel biomarkers that may transform ROP management beyond the anti-VEGF era.

Methods: We conducted a comprehensive literature review of studies published between 2001 and 2025, focusing on novel therapeutic mechanisms, biomarker discovery, and translational research in ROP.

Results: Several promising therapeutic targets have emerged, including: (1) IGF-1 supplementation and IGF-1/IGFBP3 complex therapy; (2) Omega-3 polyunsaturated fatty acids, demonstrating anti-inflammatory and anti-angiogenic properties; (3) Antioxidant therapies targeting oxidative stress pathways; (4) HIF-stabilizing agents that promote physiological vascularization; (5) Cell-based therapies using mesenchymal stem cells and (6) Non-selective beta-adrenergic receptor blockers (propranolol), which target the sympathetic drive of pathological neovascularization. Novel biomarkers under investigation and advanced imaging biomarkers using OCT angiography. Combination approaches integrating multiple pathways show particular promise.

Conclusions: Emerging therapies targeting multiple pathogenic mechanisms, combined with novel biomarkers for risk stratification and treatment monitoring, show potential for more personalized and effective ROP management. Future research should focus on validating these biomarkers in diverse populations and optimizing combination therapy protocols to minimize treatment burden while maximizing visual outcomes and systemic safety.

背景:早产儿视网膜病变(ROP)仍然是世界范围内儿童失明的主要原因。虽然抗vegf治疗已经彻底改变了ROP治疗,但对全身吸收、潜在神经发育影响和晚期再激活的担忧促使人们寻求替代治疗方法。这篇小型综述探讨了新兴的治疗靶点和新的生物标志物,这些靶点和生物标志物可能会改变ROP治疗,使其超越抗vegf时代。方法:我们对2001年至2025年间发表的研究进行了全面的文献综述,重点关注ROP的新治疗机制、生物标志物发现和转化研究。结果:出现了几个有希望的治疗靶点,包括:(1)补充IGF-1和IGF-1/IGFBP3复合物治疗;(2) Omega-3多不饱和脂肪酸,具有抗炎和抗血管生成的特性;(3)针对氧化应激途径的抗氧化治疗;(4)促进生理性血管形成的hif稳定剂;(5)使用间充质干细胞的细胞疗法和(6)非选择性β -肾上腺素能受体阻滞剂(普萘洛尔),其靶向病理新生血管的交感驱动。新的生物标志物正在研究和先进的成像生物标志物使用OCT血管造影。整合多种途径的组合方法显示出特别的前景。结论:针对多种致病机制的新兴疗法,结合用于风险分层和治疗监测的新型生物标志物,显示出更个性化和有效的ROP管理的潜力。未来的研究应侧重于在不同人群中验证这些生物标志物,并优化联合治疗方案,以最大限度地减少治疗负担,同时最大限度地提高视觉效果和系统安全性。
{"title":"Beyond anti-VEGF: expanding the therapeutic horizon and biomarker landscape in retinopathy of prematurity.","authors":"Yuxin Zhang, Qian Chen, Jianli Lv","doi":"10.3389/fped.2025.1713783","DOIUrl":"10.3389/fped.2025.1713783","url":null,"abstract":"<p><strong>Background: </strong>Retinopathy of prematurity (ROP) remains a leading cause of childhood blindness worldwide. While anti-VEGF therapy has revolutionized ROP treatment, concerns regarding systemic absorption, potential neurodevelopmental impacts, and late reactivation have spurred the quest for alternative therapeutic approaches. This mini-review examines emerging therapeutic targets and novel biomarkers that may transform ROP management beyond the anti-VEGF era.</p><p><strong>Methods: </strong>We conducted a comprehensive literature review of studies published between 2001 and 2025, focusing on novel therapeutic mechanisms, biomarker discovery, and translational research in ROP.</p><p><strong>Results: </strong>Several promising therapeutic targets have emerged, including: (1) IGF-1 supplementation and IGF-1/IGFBP3 complex therapy; (2) Omega-3 polyunsaturated fatty acids, demonstrating anti-inflammatory and anti-angiogenic properties; (3) Antioxidant therapies targeting oxidative stress pathways; (4) HIF-stabilizing agents that promote physiological vascularization; (5) Cell-based therapies using mesenchymal stem cells and (6) Non-selective beta-adrenergic receptor blockers (propranolol), which target the sympathetic drive of pathological neovascularization. Novel biomarkers under investigation and advanced imaging biomarkers using OCT angiography. Combination approaches integrating multiple pathways show particular promise.</p><p><strong>Conclusions: </strong>Emerging therapies targeting multiple pathogenic mechanisms, combined with novel biomarkers for risk stratification and treatment monitoring, show potential for more personalized and effective ROP management. Future research should focus on validating these biomarkers in diverse populations and optimizing combination therapy protocols to minimize treatment burden while maximizing visual outcomes and systemic safety.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1713783"},"PeriodicalIF":2.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence for patent ductus arteriosus-a systematic review. 人工智能治疗动脉导管未闭的系统综述。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-30 eCollection Date: 2026-01-01 DOI: 10.3389/fped.2026.1648943
Sarah Elizabeth Long, Theodor Uden, Corinna Peter, Steffen Oeltze-Jafra, Philipp Beerbaum
<p><strong>Introduction: </strong>Optimal management of patent ductus arteriosus (PDA) remains controversial. Complexity in severity appraisal, high-dimensional data, and the need for longitudinal, individualized assessment make PDA a compelling candidate for Artificial Intelligence (AI)-driven approaches. This systematic review evaluates AI research in the context of PDA, identifying strengths, limitations, and future directions.</p><p><strong>Methods: </strong>Following PRISMA 2020, databases were searched for peer-reviewed articles from January 1, 2010, to May 31, 2025. Eleven studies met inclusion criteria. Data on design, population, sources, AI methods, performance, validation, limitations, and explainability were extracted. Risk of bias was assessed using the Prediction model Risk of Bias Assessment Tool and Joanna Briggs Institute Critical Appraisal Checklist; reporting quality using the Minimum Information about Clinical AI Modeling checklist. Heterogeneity precluded meta-analysis; therefore findings were synthesized narratively.</p><p><strong>Results: </strong>Eleven studies addressed diagnosis/screening (<i>n</i> = 5), treatment-response prediction (<i>n</i> = 2), risk-factor identification (<i>n</i> = 2), treatment-complication prediction (<i>n</i> = 1), and subphenotype analysis (<i>n</i> = 1). Ten were retrospective; nine single-center, one multi-center, and one used a national registry. Sample sizes were mostly <500 (range: 66-8,369). Definitions of PDA subgroups-symptomatic and hemodynamically significant PDA-varied significantly. Populations included preterm, neonatal and pediatric cohorts, often excluding other congenital heart disease, pulmonary hypertension, or early mortality. Input data ranged from multimodal parameters to high-dimensional unimodal sources. Ten studies used supervised learning; nine traditional machine learning; five deep learning. No study performed adequate external validation. Diagnostic models achieved AUCs of 0.74-0.93, however risk of bias was high, particularly in analysis, suggesting overfitting. Models addressing other aspects showed modest performance. None of the included studies exhibited low risk of bias. Most studies addressed explainability to some degree; only one addressed clinical utility; none evaluated fairness. Reproducibility was hindered by manual preprocessing and limited sharing of data, models, or code.</p><p><strong>Conclusions: </strong>Artificial intelligence shows feasibility for supporting PDA risk stratification, diagnosis, severity assessment, and prediction of treatment-related outcomes. However, current applications remain in early, pilot-stage development and are not yet suitable for clinical implementation. Future work should prioritize clinically meaningful tasks, scientifically rigorous and bias-aware methodologies, larger and more representative cohorts, and systematic external validation. Fairness, explainability, and reproducibility must be addressed to support trans
导言:动脉导管未闭(PDA)的最佳治疗仍有争议。严重性评估的复杂性、高维数据以及对纵向、个性化评估的需求使PDA成为人工智能(AI)驱动方法的一个引人注目的候选者。本系统综述评估了PDA背景下的人工智能研究,确定了优势、局限性和未来方向。方法:使用PRISMA 2020检索数据库,检索2010年1月1日至2025年5月31日的同行评议文章。11项研究符合纳入标准。提取了设计、人口、来源、人工智能方法、性能、验证、局限性和可解释性方面的数据。采用预测模型偏倚风险评估工具和乔安娜布里格斯研究所关键评估清单评估偏倚风险;使用关于临床人工智能建模清单的最小信息报告质量。异质性排除了meta分析;因此,研究结果是综合叙述。结果:11项研究涉及诊断/筛查(n = 5)、治疗-反应预测(n = 2)、危险因素识别(n = 2)、治疗-并发症预测(n = 1)和亚表型分析(n = 1)。10项是回顾性的;9个单中心,1个多中心,1个使用国家登记。结论:人工智能显示了支持PDA风险分层、诊断、严重程度评估和治疗相关结果预测的可行性。然而,目前的应用仍处于早期,试点阶段的发展,尚不适合临床实施。未来的工作应优先考虑临床有意义的任务,科学严谨和偏见意识的方法,更大和更具代表性的队列,以及系统的外部验证。公平、可解释性和可重复性必须得到解决,以支持翻译。持续的方法改进和临床基础将是未来为这一高度脆弱的患者群体释放这些技术潜力的关键。
{"title":"Artificial intelligence for patent ductus arteriosus-a systematic review.","authors":"Sarah Elizabeth Long, Theodor Uden, Corinna Peter, Steffen Oeltze-Jafra, Philipp Beerbaum","doi":"10.3389/fped.2026.1648943","DOIUrl":"10.3389/fped.2026.1648943","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Optimal management of patent ductus arteriosus (PDA) remains controversial. Complexity in severity appraisal, high-dimensional data, and the need for longitudinal, individualized assessment make PDA a compelling candidate for Artificial Intelligence (AI)-driven approaches. This systematic review evaluates AI research in the context of PDA, identifying strengths, limitations, and future directions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Following PRISMA 2020, databases were searched for peer-reviewed articles from January 1, 2010, to May 31, 2025. Eleven studies met inclusion criteria. Data on design, population, sources, AI methods, performance, validation, limitations, and explainability were extracted. Risk of bias was assessed using the Prediction model Risk of Bias Assessment Tool and Joanna Briggs Institute Critical Appraisal Checklist; reporting quality using the Minimum Information about Clinical AI Modeling checklist. Heterogeneity precluded meta-analysis; therefore findings were synthesized narratively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Eleven studies addressed diagnosis/screening (&lt;i&gt;n&lt;/i&gt; = 5), treatment-response prediction (&lt;i&gt;n&lt;/i&gt; = 2), risk-factor identification (&lt;i&gt;n&lt;/i&gt; = 2), treatment-complication prediction (&lt;i&gt;n&lt;/i&gt; = 1), and subphenotype analysis (&lt;i&gt;n&lt;/i&gt; = 1). Ten were retrospective; nine single-center, one multi-center, and one used a national registry. Sample sizes were mostly &lt;500 (range: 66-8,369). Definitions of PDA subgroups-symptomatic and hemodynamically significant PDA-varied significantly. Populations included preterm, neonatal and pediatric cohorts, often excluding other congenital heart disease, pulmonary hypertension, or early mortality. Input data ranged from multimodal parameters to high-dimensional unimodal sources. Ten studies used supervised learning; nine traditional machine learning; five deep learning. No study performed adequate external validation. Diagnostic models achieved AUCs of 0.74-0.93, however risk of bias was high, particularly in analysis, suggesting overfitting. Models addressing other aspects showed modest performance. None of the included studies exhibited low risk of bias. Most studies addressed explainability to some degree; only one addressed clinical utility; none evaluated fairness. Reproducibility was hindered by manual preprocessing and limited sharing of data, models, or code.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Artificial intelligence shows feasibility for supporting PDA risk stratification, diagnosis, severity assessment, and prediction of treatment-related outcomes. However, current applications remain in early, pilot-stage development and are not yet suitable for clinical implementation. Future work should prioritize clinically meaningful tasks, scientifically rigorous and bias-aware methodologies, larger and more representative cohorts, and systematic external validation. Fairness, explainability, and reproducibility must be addressed to support trans","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"14 ","pages":"1648943"},"PeriodicalIF":2.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congenital pseudarthrosis of the proximal tibia: a case report. 胫骨近端先天性假关节1例。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-30 eCollection Date: 2026-01-01 DOI: 10.3389/fped.2026.1768501
Jiewei Weng, Jiaqi Wang, Tianyou Li

Congenital pseudarthrosis of the tibia (CPT) is a rare and challenging pediatric orthopedic disorder that predominantly affects the distal or middle third of the tibia, with involvement of the proximal third being exceedingly rare. Literature on this condition remains limited. This case presents proximal tibial CPT with proximal tibial dysplasia in a 7-year-old male patient with neurofibromatosis type 1. Based on the fundamental treatment principles of CPT, the child underwent pseudarthrosis resection, bone grafting, and internal fixation with a Rush rod combined with a plate. Following the achievement of initial successful union, hemiepiphysiodesis was employed to correct the genu valgus deformity. This case report proposes a hypothesis regarding the formation mechanism of proximal tibial CPT and provides clinical support for the standardized diagnosis and management of CPT.

先天性胫骨假关节(CPT)是一种罕见且具有挑战性的儿科骨科疾病,主要影响胫骨远端或中间三分之一,近端三分之一的受累极为罕见。关于这种情况的文献仍然有限。本病例为7岁男性1型神经纤维瘤病患者,伴有胫骨近端CPT伴胫骨近端发育不良。根据CPT的基本治疗原则,患儿接受假关节切除术、植骨和Rush棒联合钢板内固定。在初步成功愈合后,采用半表皮成形术矫正膝外翻畸形。本病例报告对胫骨近端CPT的形成机制提出假设,为CPT的规范化诊断和管理提供临床支持。
{"title":"Congenital pseudarthrosis of the proximal tibia: a case report.","authors":"Jiewei Weng, Jiaqi Wang, Tianyou Li","doi":"10.3389/fped.2026.1768501","DOIUrl":"10.3389/fped.2026.1768501","url":null,"abstract":"<p><p>Congenital pseudarthrosis of the tibia (CPT) is a rare and challenging pediatric orthopedic disorder that predominantly affects the distal or middle third of the tibia, with involvement of the proximal third being exceedingly rare. Literature on this condition remains limited. This case presents proximal tibial CPT with proximal tibial dysplasia in a 7-year-old male patient with neurofibromatosis type 1. Based on the fundamental treatment principles of CPT, the child underwent pseudarthrosis resection, bone grafting, and internal fixation with a Rush rod combined with a plate. Following the achievement of initial successful union, hemiepiphysiodesis was employed to correct the genu valgus deformity. This case report proposes a hypothesis regarding the formation mechanism of proximal tibial CPT and provides clinical support for the standardized diagnosis and management of CPT.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"14 ","pages":"1768501"},"PeriodicalIF":2.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: Sengers syndrome caused by a novel 7.6 kb AGK deletion misdiagnosed as isolated congenital cataract. 病例报告:一种新的7.6 kb AGK缺失引起的seners综合征被误诊为孤立性先天性白内障。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-30 eCollection Date: 2026-01-01 DOI: 10.3389/fped.2026.1714952
Xingwang Gong, Yue Liu, Hui Liang

The diagnosis of Sengers syndrome, a rare mitochondrial disorder, is often challenged by phenotypic mimicry. We report a diagnostically instructive case of a 4-month-old female who presented with the classic triad of congenital cataracts, hypertrophic cardiomyopathy, and lactic acidosis. Initial whole-exome sequencing (WES) was confounded by the finding of a heterozygous variant in CRYBA2 and only a single heterozygous nonsense mutation in AGK (c.409C>T, p.Arg137*). The persistence of a multisystemic phenotype inconsistent with an isolated cataract disorder prompted further investigation. Copy number variation (CNV) analysis of the WES data revealed a large heterozygous deletion in AGK, which breakpoint-specific polymerase chain reaction and Sanger sequencing precisely characterized as a novel 7.6 kb deletion (chr7:141297542-141305156). This confirmed compound heterozygosity, yielding a definitive diagnosis of Sengers syndrome and reclassifying the CRYBA2 variant as incidental. Crucially, breakpoint analysis indicated a non-Alu-mediated mechanism for the deletion. This case highlights the critical importance of CNV analysis in resolving genetically ambiguous autosomal recessive cases and provides novel insight into the structural mutational landscape of AGK.

seners综合征是一种罕见的线粒体疾病,其诊断常常受到表型模仿的挑战。我们报告一个4个月大的女性谁提出了先天性白内障,肥厚性心肌病和乳酸性酸中毒的经典三合一诊断指导性的情况下。最初的全外显子组测序(WES)被CRYBA2的杂合变异和AGK的单杂合无义突变(c.409C>T, p.Arg137*)所混淆。与孤立性白内障不一致的多系统表型的持续存在促使进一步的研究。WES数据的拷贝数变异(CNV)分析显示,AGK中存在大量杂合缺失,断点特异性聚合酶链反应和Sanger测序精确地描述了这一新的7.6 kb缺失(chr7:141297542-141305156)。这证实了复合杂合性,从而明确诊断为senger综合征,并将CRYBA2变异重新分类为偶然的。至关重要的是,断点分析表明了非alu介导的缺失机制。该病例强调了CNV分析在解决遗传模糊常染色体隐性病例中的关键重要性,并为AGK的结构突变景观提供了新的见解。
{"title":"Case Report: Sengers syndrome caused by a novel 7.6 kb AGK deletion misdiagnosed as isolated congenital cataract.","authors":"Xingwang Gong, Yue Liu, Hui Liang","doi":"10.3389/fped.2026.1714952","DOIUrl":"10.3389/fped.2026.1714952","url":null,"abstract":"<p><p>The diagnosis of Sengers syndrome, a rare mitochondrial disorder, is often challenged by phenotypic mimicry. We report a diagnostically instructive case of a 4-month-old female who presented with the classic triad of congenital cataracts, hypertrophic cardiomyopathy, and lactic acidosis. Initial whole-exome sequencing (WES) was confounded by the finding of a heterozygous variant in <i>CRYBA2</i> and only a single heterozygous nonsense mutation in <i>AGK</i> (c.409C>T, p.Arg137*). The persistence of a multisystemic phenotype inconsistent with an isolated cataract disorder prompted further investigation. Copy number variation (CNV) analysis of the WES data revealed a large heterozygous deletion in <i>AGK</i>, which breakpoint-specific polymerase chain reaction and Sanger sequencing precisely characterized as a novel 7.6 kb deletion (chr7:141297542-141305156). This confirmed compound heterozygosity, yielding a definitive diagnosis of Sengers syndrome and reclassifying the <i>CRYBA2</i> variant as incidental. Crucially, breakpoint analysis indicated a non-Alu-mediated mechanism for the deletion. This case highlights the critical importance of CNV analysis in resolving genetically ambiguous autosomal recessive cases and provides novel insight into the structural mutational landscape of <i>AGK</i>.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"14 ","pages":"1714952"},"PeriodicalIF":2.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12903264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the classification performance and cost-effectiveness of classification criteria in children with systemic lupus erythematosus. 评价系统性红斑狼疮儿童分类标准的分类效果和成本-效果。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-30 eCollection Date: 2026-01-01 DOI: 10.3389/fped.2026.1745252
Ana Luisa Rodríguez-Lozano, Alejandro Gabriel González-Garay, Miguel Ángel Villasis-Keever, Ruth G Nájera-Velázquez, Marimar Sáez-de-Ocariz, Selma Cecilia Scheffler-Mendoza, Francisco Eduardo Rivas-Larrauri, Marco Antonio Yamazaki-Nakashimada, Silvestre García-De La Puente

Background: Childhood-onset systemic lupus erythematosus (cSLE) is a chronic autoimmune disease. In Latin America, the utility of the existing lupus classification criteria and their economic implications remain unexplored.

Objective: To evaluate and compare the utility and cost-effectiveness of the ACR-1997, SLICC-2012, and ACR/EULAR-2019 classification criteria in children with suspected cSLE.

Methods: We prospectively included subjects aged ≤17 who presented to the Immunology Department with suspected cSLE and consented to participate in the study. Exclusion criteria were pregnancy, tuberculosis, immunosuppressive therapy, malignancies, or insufficient data to apply the classification criteria. The ACR-1997, SLICC-2012, and ACR/EULAR-2019 lupus criteria were applied, followed by a referral for expert consensus diagnosis, which served as the standard of reference. We calculated the classification performance (how well a set of classification criteria assigns an individual to SLE or no-cSLE, measuring sensitivity, specificity, among others), direct healthcare costs for each classification, and developed a decision tree and quadrant graph for economic evaluation.

Results: Ninety-six subjects (83% female) with a median age of 13.5 years were included in this study. The expert consensus diagnosis identified cSLE in 43 subjects; ACR and ACR/EULAR each identified 42 cases, while SLICC identified 56. The sensitivity was 98% for SLICC-2012, 84% for ACR-1997, and ACR/EULAR-2019, p = 0.000). The cost per subject per classification was USD 287.62 for SLICC-2012, USD 174.97 for ACR-1997, and USD 310.36 for ACR/EULAR-2019 (p = 0.596).

Conclusion: The SLICC-2012 criteria were the most sensitive for the classification of SLE, but not the most cost-effective. ACR-1997 remains the most cost-effective tool in specialized settings; however, the higher sensitivity of SLICC-2012 supports its use to improve early referral.

背景:儿童期系统性红斑狼疮(cSLE)是一种慢性自身免疫性疾病。在拉丁美洲,现有狼疮分类标准的效用及其经济影响仍未得到探讨。目的:评价和比较ACR-1997、SLICC-2012和ACR/EULAR-2019分类标准在疑似cSLE患儿中的效用和成本效益。方法:我们前瞻性地纳入年龄≤17岁、到免疫学部门就诊并同意参与研究的疑似cSLE患者。排除标准为妊娠、肺结核、免疫抑制治疗、恶性肿瘤或资料不足,无法应用分类标准。采用ACR-1997、SLICC-2012和ACR/EULAR-2019狼疮标准,转诊专家共识诊断,作为参考标准。我们计算了分类性能(一组分类标准将个体分配到SLE或非SLE的程度,测量敏感性,特异性等),每个分类的直接医疗成本,并开发了决策树和象限图用于经济评估。结果:96名受试者(83%为女性)纳入本研究,中位年龄为13.5岁。专家一致诊断为cSLE 43例;ACR和ACR/EULAR各发现42例,SLICC发现56例。SLICC-2012的敏感性为98%,ACR-1997和ACR/EULAR-2019的敏感性为84%,p = 0.000)。SLICC-2012的每个受试者每个分类的成本为287.62美元,ACR-1997为174.97美元,ACR/EULAR-2019为310.36美元(p = 0.596)。结论:SLICC-2012标准对SLE的分类最敏感,但不是最划算的。ACR-1997仍然是专业环境中最具成本效益的工具;然而,SLICC-2012的较高敏感性支持其用于改善早期转诊。
{"title":"Evaluation of the classification performance and cost-effectiveness of classification criteria in children with systemic lupus erythematosus.","authors":"Ana Luisa Rodríguez-Lozano, Alejandro Gabriel González-Garay, Miguel Ángel Villasis-Keever, Ruth G Nájera-Velázquez, Marimar Sáez-de-Ocariz, Selma Cecilia Scheffler-Mendoza, Francisco Eduardo Rivas-Larrauri, Marco Antonio Yamazaki-Nakashimada, Silvestre García-De La Puente","doi":"10.3389/fped.2026.1745252","DOIUrl":"10.3389/fped.2026.1745252","url":null,"abstract":"<p><strong>Background: </strong>Childhood-onset systemic lupus erythematosus (cSLE) is a chronic autoimmune disease. In Latin America, the utility of the existing lupus classification criteria and their economic implications remain unexplored.</p><p><strong>Objective: </strong>To evaluate and compare the utility and cost-effectiveness of the ACR-1997, SLICC-2012, and ACR/EULAR-2019 classification criteria in children with suspected cSLE.</p><p><strong>Methods: </strong>We prospectively included subjects aged ≤17 who presented to the Immunology Department with suspected cSLE and consented to participate in the study. Exclusion criteria were pregnancy, tuberculosis, immunosuppressive therapy, malignancies, or insufficient data to apply the classification criteria. The ACR-1997, SLICC-2012, and ACR/EULAR-2019 lupus criteria were applied, followed by a referral for expert consensus diagnosis, which served as the standard of reference. We calculated the classification performance (how well a set of classification criteria assigns an individual to SLE or no-cSLE, measuring sensitivity, specificity, among others), direct healthcare costs for each classification, and developed a decision tree and quadrant graph for economic evaluation.</p><p><strong>Results: </strong>Ninety-six subjects (83% female) with a median age of 13.5 years were included in this study. The expert consensus diagnosis identified cSLE in 43 subjects; ACR and ACR/EULAR each identified 42 cases, while SLICC identified 56. The sensitivity was 98% for SLICC-2012, 84% for ACR-1997, and ACR/EULAR-2019, <i>p</i> = 0.000). The cost per subject per classification was USD 287.62 for SLICC-2012, USD 174.97 for ACR-1997, and USD 310.36 for ACR/EULAR-2019 (<i>p</i> = 0.596).</p><p><strong>Conclusion: </strong>The SLICC-2012 criteria were the most sensitive for the classification of SLE, but not the most cost-effective. ACR-1997 remains the most cost-effective tool in specialized settings; however, the higher sensitivity of SLICC-2012 supports its use to improve early referral.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"14 ","pages":"1745252"},"PeriodicalIF":2.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Family matters: the role of parents in adolescent motivation and exercise promotion. 家庭问题:父母在青少年动机和运动促进中的作用。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-30 eCollection Date: 2025-01-01 DOI: 10.3389/fped.2025.1641507
Dan Bai, Mingdong Wu, Baixia Li, Danheng Zheng, Xiaoming Liu

Objectives: This study aimed to investigate the relationship between parents' exercise habits (PEH), exercise motivation (EMO), and exercise behavior (EB) among junior high school students in Shanghai, with a particular focus on the mediating effects of different types of motivation.

Methods: A cross-sectional online survey was conducted in Shanghai from February to June 2023 using purposive sampling. A total of 803 questionnaires were distributed through online platforms, and 777 valid responses were included in the final analysis. Structural Equation Modeling (SEM) was applied using SmartPLS 4.0 to examine the direct and indirect pathways among variables.

Results: The results showed that PEH was positively associated with EB both directly and indirectly. Among the five types of EMO, competence motivation (CMO) and fitness motivation (FMO) were positively related to EB, whereas social motivation (SMO) was negatively related to EB. Mediation analysis indicated that CMO served as a significant positive mediator, while SMO acted as a significant negative mediator in the relationship between PEH and EB. Enjoyment motivation (EJMO) and appearance motivation (AMO) were not significantly associated with EB. In addition, PEH was positively associated with all five dimensions of EMO.

Conclusions: PEH play an important role in shaping adolescents' EB through distinct motivational pathways. Autonomous motivations, particularly competence-related motivation, facilitated exercise engagement, whereas socially controlled motivation was associated with lower EB. These findings highlight the need for family- and school-based interventions that emphasize autonomy and competence support rather than social pressure to promote sustained physical activity (PA) among adolescents.

目的:探讨上海市初中生父母运动习惯(PEH)、运动动机(EMO)和运动行为(EB)之间的关系,并重点研究不同类型动机的中介作用。方法:于2023年2月至6月在上海市采用有目的抽样方法进行横断面在线调查。通过网络平台共发放问卷803份,最终分析有效回复777份。使用SmartPLS 4.0应用结构方程建模(SEM)来检查变量之间的直接和间接途径。结果:PEH与EB有直接和间接的正相关关系。在5种情绪情绪类型中,胜任动机(CMO)和健身动机(FMO)与情绪情绪呈显著正相关,社交动机(SMO)与情绪情绪呈显著负相关。中介分析表明,在PEH与EB的关系中,CMO为显著的正中介,SMO为显著的负中介。享受动机(EJMO)和外观动机(AMO)与EB无显著相关。此外,PEH与EMO的五个维度均呈正相关。结论:PEH通过不同的动机通路对青少年EB的形成起重要作用。自主动机,特别是与能力相关的动机,促进了运动投入,而社会控制动机与较低的EB有关。这些发现强调需要以家庭和学校为基础的干预措施,强调自主和能力支持,而不是社会压力,以促进青少年的持续体育活动。
{"title":"Family matters: the role of parents in adolescent motivation and exercise promotion.","authors":"Dan Bai, Mingdong Wu, Baixia Li, Danheng Zheng, Xiaoming Liu","doi":"10.3389/fped.2025.1641507","DOIUrl":"10.3389/fped.2025.1641507","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to investigate the relationship between parents' exercise habits (PEH), exercise motivation (EMO), and exercise behavior (EB) among junior high school students in Shanghai, with a particular focus on the mediating effects of different types of motivation.</p><p><strong>Methods: </strong>A cross-sectional online survey was conducted in Shanghai from February to June 2023 using purposive sampling. A total of 803 questionnaires were distributed through online platforms, and 777 valid responses were included in the final analysis. Structural Equation Modeling (SEM) was applied using SmartPLS 4.0 to examine the direct and indirect pathways among variables.</p><p><strong>Results: </strong>The results showed that PEH was positively associated with EB both directly and indirectly. Among the five types of EMO, competence motivation (CMO) and fitness motivation (FMO) were positively related to EB, whereas social motivation (SMO) was negatively related to EB. Mediation analysis indicated that CMO served as a significant positive mediator, while SMO acted as a significant negative mediator in the relationship between PEH and EB. Enjoyment motivation (EJMO) and appearance motivation (AMO) were not significantly associated with EB. In addition, PEH was positively associated with all five dimensions of EMO.</p><p><strong>Conclusions: </strong>PEH play an important role in shaping adolescents' EB through distinct motivational pathways. Autonomous motivations, particularly competence-related motivation, facilitated exercise engagement, whereas socially controlled motivation was associated with lower EB. These findings highlight the need for family- and school-based interventions that emphasize autonomy and competence support rather than social pressure to promote sustained physical activity (PA) among adolescents.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1641507"},"PeriodicalIF":2.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report of Behcet's disease in a child with trisomy 8 and literature review. 8三体儿童Behcet病1例报告并文献复习。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-30 eCollection Date: 2025-01-01 DOI: 10.3389/fped.2025.1750552
Kaixi Zhang, Chenxi Wei, Lijun Jiang, Xue Zhao, Qingxiao Su, Xingjie Qi, Hui Zhao, Zanhua Rong

Objective: Report a case of Behcet's disease (BD) in a child with trisomy 8 mosaicism (T8M), providing insights for the diagnosis, treatment, and prognosis of this condition.

Methods: The clinical data of an 11-year-old girl with T8M mosaicism and BD who was admitted to our hospital in August 2022 were retrospectively analyzed, and the relevant literature was reviewed.

Results: The main clinical manifestations of the child were recurrent oral ulcers, vulvar ulcers, fever, and joint deformities of both hands. Inflammatory markers (CRP, white blood cell, IL-6, IL-17) were significantly increased, and complement C3 and C4 were decreased. Cranial MRI showed dysplasia of the corpus callosum and ventriculomegaly. BD was diagnosed according to the international standard, and genetic testing confirmed a karyotype of 47, XX, +8[9]/46, XX [31] (chimerism ratio 22.50%). After treatment with glucocorticoids combined with immunosuppressants (including thalidomide, etc.), the ulcer and inflammatory markers were rapidly relieved. However, the ulcer recurred two and a half years after drug withdrawal.

Conclusions: T8M may be detected in the autoinflammatory stage of BD, before any overt hematologic manifestations appear. Children presenting with BD-like features plus developmental anomalies or refractory autoinflammation should undergo karyotyping to establish the presence or absence of T8M, thereby informing both clinical management and genetic counseling.

目的:报告1例8三体嵌合体(T8M)患儿白塞病(BD),为该病的诊断、治疗及预后提供参考。方法:回顾性分析我院2022年8月收治的1例11岁女童T8M嵌合合并BD的临床资料,并复习相关文献。结果:患儿的主要临床表现为复发性口腔溃疡、外阴溃疡、发热、双手关节畸形。炎症标志物(CRP、白细胞、IL-6、IL-17)显著升高,补体C3、C4降低。头颅MRI显示胼胝体发育不良,脑室肿大。按照国际标准诊断为BD,基因检测证实核型为47、XX、+8[9]/46、XX[31](嵌合比22.50%)。经糖皮质激素联合免疫抑制剂(包括沙利度胺等)治疗后,溃疡和炎症指标迅速缓解。然而,停药两年半后,溃疡复发。结论:在任何明显的血液学表现出现之前,可在BD自身炎症期检测到T8M。以bd样特征加上发育异常或难治性自身炎症为表现的儿童应进行核型分析,以确定是否存在T8M,从而为临床管理和遗传咨询提供信息。
{"title":"A case report of Behcet's disease in a child with trisomy 8 and literature review.","authors":"Kaixi Zhang, Chenxi Wei, Lijun Jiang, Xue Zhao, Qingxiao Su, Xingjie Qi, Hui Zhao, Zanhua Rong","doi":"10.3389/fped.2025.1750552","DOIUrl":"10.3389/fped.2025.1750552","url":null,"abstract":"<p><strong>Objective: </strong>Report a case of Behcet's disease (BD) in a child with trisomy 8 mosaicism (T8M), providing insights for the diagnosis, treatment, and prognosis of this condition.</p><p><strong>Methods: </strong>The clinical data of an 11-year-old girl with T8M mosaicism and BD who was admitted to our hospital in August 2022 were retrospectively analyzed, and the relevant literature was reviewed.</p><p><strong>Results: </strong>The main clinical manifestations of the child were recurrent oral ulcers, vulvar ulcers, fever, and joint deformities of both hands. Inflammatory markers (CRP, white blood cell, IL-6, IL-17) were significantly increased, and complement C3 and C4 were decreased. Cranial MRI showed dysplasia of the corpus callosum and ventriculomegaly. BD was diagnosed according to the international standard, and genetic testing confirmed a karyotype of 47, XX, +8[9]/46, XX [31] (chimerism ratio 22.50%). After treatment with glucocorticoids combined with immunosuppressants (including thalidomide, etc.), the ulcer and inflammatory markers were rapidly relieved. However, the ulcer recurred two and a half years after drug withdrawal.</p><p><strong>Conclusions: </strong>T8M may be detected in the autoinflammatory stage of BD, before any overt hematologic manifestations appear. Children presenting with BD-like features plus developmental anomalies or refractory autoinflammation should undergo karyotyping to establish the presence or absence of T8M, thereby informing both clinical management and genetic counseling.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1750552"},"PeriodicalIF":2.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The surgical efficiency of Kirschner wire sleeve-assisted removal of elastic intramedullary nails: a comparative study. 克氏针套辅助下弹性髓内钉取出术的疗效对比研究。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-29 eCollection Date: 2025-01-01 DOI: 10.3389/fped.2025.1689452
Xue-Tang Lin, Lin-Xiong Wang, Xiao-Cong Chen, Wei-Peng Gong, Shang-Guan Shang-Lin, Dong-Qing Huang, Shu-Mu Yang, Na-Ling Yi, Long-Feng Tang

Background: Elastic intramedullary nails (ESIN) are widely used for pediatric fractures; however, their removal poses technical challenges. Currently, there are limited reports on improvements in ESIN removal techniques. This study aimed to explore the clinical efficacy of Kirschner Wire (K-wire) sleeve-assisted ESIN removal surgery and to provide new references for ESIN extraction in orthopedic surgery.

Methods: This retrospective study included 32 patients who underwent ESIN removal surgery at our hospital between October 2020 and July 2024. Patients were retrospectively assigned to two groups based on surgical method: the conventional instrument removal group and the K-wire cannula-assisted removal group. The efficacy of K-wire sleeve-assisted ESIN removal surgery was then compared with that of the traditional method.

Results: The K-wire sleeve group (observation group, n = 17) exhibited a significantly shorter operative time (4.65 ± 1.12 vs. 11.33 ± 1.47 min/nail, p < 0.001) and significantly smaller incisions (0.95 ± 0.11 vs. 1.43 ± 0.33 cm/nail, p < 0.001) when compared to traditional methodology (control group, n = 15). Among the 32 patients, no cases of postoperative incision infection, intraoperative nerve injury, or vascular injury were observed.

Conclusion: The Kirschner Wire (K-wire) sleeve-assisted ESIN removal technique provided a minimally invasive and cost-effective alternative to traditional methods.

背景:弹性髓内钉(ESIN)广泛应用于儿童骨折;然而,它们的移除带来了技术上的挑战。目前,关于ESIN去除技术的改进报道有限。本研究旨在探讨克氏针(k -丝)套管辅助ESIN取出手术的临床疗效,为骨科手术ESIN取出提供新的参考。方法:本回顾性研究纳入了2020年10月至2024年7月在我院行ESIN去除手术的32例患者。根据手术方式将患者回顾性分为两组:常规器械取出组和k线套管辅助取出组。比较k丝套管辅助ESIN取出术与传统方法的疗效。结果:k针套组(n = 17)手术时间明显缩短(4.65±1.12 vs 11.33±1.47 min/根,p p n = 15)。32例患者无术后切口感染、术中神经损伤、血管损伤。结论:克氏针(k -丝)套管辅助ESIN取出技术是传统方法的一种微创、经济的替代方法。
{"title":"The surgical efficiency of Kirschner wire sleeve-assisted removal of elastic intramedullary nails: a comparative study.","authors":"Xue-Tang Lin, Lin-Xiong Wang, Xiao-Cong Chen, Wei-Peng Gong, Shang-Guan Shang-Lin, Dong-Qing Huang, Shu-Mu Yang, Na-Ling Yi, Long-Feng Tang","doi":"10.3389/fped.2025.1689452","DOIUrl":"10.3389/fped.2025.1689452","url":null,"abstract":"<p><strong>Background: </strong>Elastic intramedullary nails (ESIN) are widely used for pediatric fractures; however, their removal poses technical challenges. Currently, there are limited reports on improvements in ESIN removal techniques. This study aimed to explore the clinical efficacy of Kirschner Wire (K-wire) sleeve-assisted ESIN removal surgery and to provide new references for ESIN extraction in orthopedic surgery.</p><p><strong>Methods: </strong>This retrospective study included 32 patients who underwent ESIN removal surgery at our hospital between October 2020 and July 2024. Patients were retrospectively assigned to two groups based on surgical method: the conventional instrument removal group and the K-wire cannula-assisted removal group. The efficacy of K-wire sleeve-assisted ESIN removal surgery was then compared with that of the traditional method.</p><p><strong>Results: </strong>The K-wire sleeve group (observation group, <i>n</i> = 17) exhibited a significantly shorter operative time (4.65 ± 1.12 vs. 11.33 ± 1.47 min/nail, <i>p</i> < 0.001) and significantly smaller incisions (0.95 ± 0.11 vs. 1.43 ± 0.33 cm/nail, <i>p</i> < 0.001) when compared to traditional methodology (control group, <i>n</i> = 15). Among the 32 patients, no cases of postoperative incision infection, intraoperative nerve injury, or vascular injury were observed.</p><p><strong>Conclusion: </strong>The Kirschner Wire (K-wire) sleeve-assisted ESIN removal technique provided a minimally invasive and cost-effective alternative to traditional methods.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1689452"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12894239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: Newly discovered ELN gene mutation in congenital heart disease: case analysis and review. 病例报告:先天性心脏病新发现的ELN基因突变:病例分析与回顾。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-29 eCollection Date: 2026-01-01 DOI: 10.3389/fped.2026.1671066
Peiwen Cheng, Guozhen Wang, Jialin Qiu, Xia Xie, Yong An

Introduction: Supravalvular aortic stenosis (SVAS) is a rare left ventricular outflow tract obstruction, most commonly caused by pathogenic variants in ELN. Truncating variants in exons 1-29 typically produce non-syndromic SVAS through elastin haploinsufficiency, whereas C-terminal variants are linked to autosomal dominant cutis laxa. However, clinically and mechanistically well-characterized variants in the distal part of this "stenotic zone," such as exon 28, remain uncommon.

Methods: We conducted a retrospective family-based case report with standardized clinical evaluation, serial echocardiography, and trio whole-exome sequencing with Sanger confirmation and conservation analysis.

Results: A female infant presented at 1 month with severe sinotubular junction narrowing (Z-score -4.8, peak gradient 24 mmHg), severe peripheral pulmonary artery stenosis, a small atrial septal defect, and moderate mitral regurgitation. Her father had severe SVAS with mild PPAS and prior aortic root enlargement, without syndromic features. Trio sequencing identified a novel heterozygous ELN exon 28 frameshift variant, c.1879_1883dup (p.Ala629LeufsTer15), inherited from the father. Ala629 is fully conserved, and the duplication introduces a premature stop codon, consistent with nonsense-mediated decay and elastin haploinsufficiency. At 9 months, SVAS progressed (peak gradient 35 mmHg), while PPAS gradients regressed by >40%.

Conclusion: This novel exon 28 ELN frameshift expands the non-syndromic SVAS spectrum and illustrates a characteristic pattern of progressive aortic stenosis with improving PPAS, supporting ELN testing and targeted longitudinal surveillance in similar patients and families.

引言:瓣上主动脉瓣狭窄(SVAS)是一种罕见的左心室流出道梗阻,最常由ELN的致病变异引起。外显子1-29的截断变异体通常通过弹性蛋白单倍不全产生非综合征性SVAS,而c端变异体与常染色体显性皮肤松弛症有关。然而,在临床上和机械上,在这个“狭窄区”的远端,如外显子28,仍然不常见。方法:我们进行了一项基于家庭的回顾性病例报告,包括标准化的临床评估、连续超声心动图和三组全外显子组测序,并进行了Sanger确认和保守分析。结果:1例女婴在1个月时出现严重的窦小管交界处狭窄(z评分-4.8,峰值梯度24 mmHg),严重的肺动脉外周狭窄,小房间隔缺损,中度二尖瓣反流。她的父亲患有严重的SVAS伴轻度PPAS,既往主动脉根部肿大,无综合征特征。三人测序鉴定出一种新的杂合ELN外显子28移码变异c.1879_1883dup (p.Ala629LeufsTer15),遗传自父亲。Ala629是完全保守的,重复引入了一个过早的终止密码子,与无义介导的衰变和弹性蛋白单倍不足一致。9个月时,SVAS进展(峰值梯度为35 mmHg),而PPAS梯度下降了40%。结论:这种新的外显子28 ELN移码扩展了非综合征性SVAS谱,并阐明了进行性主动脉狭窄与PPAS改善的特征性模式,支持ELN检测和类似患者和家庭的靶向纵向监测。
{"title":"Case Report: Newly discovered ELN gene mutation in congenital heart disease: case analysis and review.","authors":"Peiwen Cheng, Guozhen Wang, Jialin Qiu, Xia Xie, Yong An","doi":"10.3389/fped.2026.1671066","DOIUrl":"10.3389/fped.2026.1671066","url":null,"abstract":"<p><strong>Introduction: </strong>Supravalvular aortic stenosis (SVAS) is a rare left ventricular outflow tract obstruction, most commonly caused by pathogenic variants in ELN. Truncating variants in exons 1-29 typically produce non-syndromic SVAS through elastin haploinsufficiency, whereas C-terminal variants are linked to autosomal dominant cutis laxa. However, clinically and mechanistically well-characterized variants in the distal part of this \"stenotic zone,\" such as exon 28, remain uncommon.</p><p><strong>Methods: </strong>We conducted a retrospective family-based case report with standardized clinical evaluation, serial echocardiography, and trio whole-exome sequencing with Sanger confirmation and conservation analysis.</p><p><strong>Results: </strong>A female infant presented at 1 month with severe sinotubular junction narrowing (Z-score -4.8, peak gradient 24 mmHg), severe peripheral pulmonary artery stenosis, a small atrial septal defect, and moderate mitral regurgitation. Her father had severe SVAS with mild PPAS and prior aortic root enlargement, without syndromic features. Trio sequencing identified a novel heterozygous ELN exon 28 frameshift variant, c.1879_1883dup (p.Ala629LeufsTer15), inherited from the father. Ala629 is fully conserved, and the duplication introduces a premature stop codon, consistent with nonsense-mediated decay and elastin haploinsufficiency. At 9 months, SVAS progressed (peak gradient 35 mmHg), while PPAS gradients regressed by >40%.</p><p><strong>Conclusion: </strong>This novel exon 28 ELN frameshift expands the non-syndromic SVAS spectrum and illustrates a characteristic pattern of progressive aortic stenosis with improving PPAS, supporting ELN testing and targeted longitudinal surveillance in similar patients and families.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"14 ","pages":"1671066"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12894336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elastic stable intramedullary nailing alone for unicameral bone cysts of the humerus in children: a mid-term follow-up study. 弹性稳定髓内钉治疗儿童肱骨单股骨囊肿:一项中期随访研究。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2026-01-29 eCollection Date: 2026-01-01 DOI: 10.3389/fped.2026.1760767
Shoushen Liu, Fujiang Li, Yanzhou Wang, Mingang Zhang, Tianyou Li

Introduction: Unicameral bone cyst (UBC) is a common disease in children. There are several different treatment modalities for this condition. Elastic stable intramedullary nail (ESIN) insertion alone was a minimally invasive method that allows for cyst drainage and fracture prevention; however, the treatment outcome remains unclear and inadequately classified. We aimed to evaluate the outcomes of pediatric humeral UBC treated only with ESIN insertion.

Methods: This was a retrospective case series study. Data records included patient demographics, fracture classification, cyst size, treatment strategy, and complications. The Capanna classification was used to determine the outcomes. The potential influential factors for complete healing were analyzed.

Results: A total of 22 patients with an average age at surgery of 7.2 years were included. The average follow-up was 5.0 years (range 2.1-12 years). There were 3 (13.64%) type I, 8 (36.36%) type II, 3 (13.64%) type III, 8 (36.36%) type IV. 2163;. The complete healing rate (type I) and effective rate (type I, II) were 13.64% and 50%, respectively. No factors significantly influenced complete healing. At the last follow-up visit, none of the patients experienced pain or refracture, and their shoulder motion was unlimited.

Conclusion: In our study, the use of ESIN insertion alone to treat humeral UBC, on the basis of the Capanna classification, resulted in a complete healing rate of 13.64% and an overall effective rate of 50%.

单房骨囊肿(Unicameral bone囊肿,UBC)是儿童常见病。针对这种情况有几种不同的治疗方法。弹性稳定髓内钉(ESIN)单独插入是一种微创方法,允许囊肿引流和骨折预防;然而,治疗结果仍然不清楚,分类也不充分。我们的目的是评估仅用ESIN插入治疗儿童肱骨UBC的结果。方法:回顾性病例系列研究。数据记录包括患者人口统计、骨折分类、囊肿大小、治疗策略和并发症。使用Capanna分类来确定结果。分析了影响完全愈合的潜在因素。结果:共纳入22例患者,平均手术年龄为7.2岁。平均随访5.0年(2.1-12年)。ⅰ型3例(13.64%),ⅱ型8例(36.36%),ⅲ型3例(13.64%),ⅳ型8例(36.36%)。完全治愈率(I型)为13.64%,有效率(I型、II型)为50%。无明显影响完全愈合的因素。在最后一次随访中,没有患者出现疼痛或再骨折,他们的肩部运动是无限制的。结论:在我们的研究中,在Capanna分类的基础上,单独使用ESIN插入治疗肱骨UBC,完全愈合率为13.64%,总有效率为50%。
{"title":"Elastic stable intramedullary nailing alone for unicameral bone cysts of the humerus in children: a mid-term follow-up study.","authors":"Shoushen Liu, Fujiang Li, Yanzhou Wang, Mingang Zhang, Tianyou Li","doi":"10.3389/fped.2026.1760767","DOIUrl":"10.3389/fped.2026.1760767","url":null,"abstract":"<p><strong>Introduction: </strong>Unicameral bone cyst (UBC) is a common disease in children. There are several different treatment modalities for this condition. Elastic stable intramedullary nail (ESIN) insertion alone was a minimally invasive method that allows for cyst drainage and fracture prevention; however, the treatment outcome remains unclear and inadequately classified. We aimed to evaluate the outcomes of pediatric humeral UBC treated only with ESIN insertion.</p><p><strong>Methods: </strong>This was a retrospective case series study. Data records included patient demographics, fracture classification, cyst size, treatment strategy, and complications. The Capanna classification was used to determine the outcomes. The potential influential factors for complete healing were analyzed.</p><p><strong>Results: </strong>A total of 22 patients with an average age at surgery of 7.2 years were included. The average follow-up was 5.0 years (range 2.1-12 years). There were 3 (13.64%) type I, 8 (36.36%) type II, 3 (13.64%) type III, 8 (36.36%) type IV. 2163;. The complete healing rate (type I) and effective rate (type I, II) were 13.64% and 50%, respectively. No factors significantly influenced complete healing. At the last follow-up visit, none of the patients experienced pain or refracture, and their shoulder motion was unlimited.</p><p><strong>Conclusion: </strong>In our study, the use of ESIN insertion alone to treat humeral UBC, on the basis of the Capanna classification, resulted in a complete healing rate of 13.64% and an overall effective rate of 50%.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"14 ","pages":"1760767"},"PeriodicalIF":2.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12894267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1